The Graveyard › 2023
Stocks that died in 2023
158 of the Graveyard's US stocks stopped trading in 2023: 83 collapsed on the way out, 65 were bought or merged, the rest left for other reasons (a merger, a move to another market, a delisting) or reasons our data does not record. Biggest first, by their peak market value.
Ending: all · collapsed · fell hard · left without a crash · was bought or merged
Sector: all · Airlines · Auto Dealers · Autos & Aerospace · Banks · Brokers & Exchanges · Chemicals & Drugs · Construction · Department Stores · Electronics · Engineering & Consulting · Entertainment · Food · Furniture · Health Care · Holding & Investment Cos · Home Furnishing Stores · Instruments & Medical Devices · Lending · Machinery & Computers · Metal Products · Oil & Gas · Other · Paper · Restaurants · Retail · Software & Services · Steel & Metals · Telecom & Media · Trucking · Utilities · Wholesale
29 of 158 match.
- Seagen Inc (SGEN) · $43.2 billion at peak · left without a crash
- Intercept Pharma Inc (ICPT) · $9.0 billion at peak · collapsed
- Reata Pharmaceuticals Inc (RETA) · $6.9 billion at peak · was bought or merged
- Amyris Inc (AMRS) · $6.0 billion at peak · collapsed
- Iveric Bio Inc (ISEE) · $5.5 billion at peak · was bought or merged
- Sorrento Therapeutics Inc (SRNE) · $4.6 billion at peak · collapsed
- Sio Gene Therapies Inc (SIOX) · $3.0 billion at peak · collapsed
- Heska Corp (HSKA) · $2.9 billion at peak · was bought or merged
- Aduro Biotech Inc (KDNY) · $2.7 billion at peak · was bought or merged
- Spectrum Pharmaceuticals Inc (SPPI) · $2.6 billion at peak · collapsed
- Lannett Co Inc (LCI) · $2.5 billion at peak · collapsed
- Infinity Pharmaceuticals Inc (INFI) · $2.4 billion at peak · collapsed
- Cti Biopharma Corp (CTIC) · $2.1 billion at peak · collapsed
- Oncosec Medical Inc (ONCS) · $2.0 billion at peak · collapsed
- Athenex Inc (ATNX) · $1.6 billion at peak · collapsed
- Meridian Bioscience Inc (VIVO) · $1.5 billion at peak · was bought or merged
- Vical Inc (BBI) · $1.4 billion at peak · collapsed
- Humanigen Inc (HGEN) · $1.3 billion at peak · collapsed
- Chase Corp (CCF) · $1.2 billion at peak · was bought or merged
- Biodel Inc (ALBO) · $931 million at peak · collapsed
- Jounce Therapeutics Inc (JNCE) · $920 million at peak · collapsed
- Aveo Pharmaceuticals Inc (AVEO) · $895 million at peak · collapsed
- Bellicum Pharmaceuticals Inc (BLCM) · $837 million at peak · collapsed
- Polarityte Inc (PTE) · $830 million at peak · collapsed
- Transcept Pharmaceuticals (PRTK) · $783 million at peak · collapsed
- Sevion Therapeutics Inc (ELOX) · $778 million at peak · collapsed
- Calithera Biosciences Inc (CALA) · $709 million at peak · collapsed
- Athersys Inc (ATHX) · $680 million at peak · collapsed
- Concert Pharmaceuticls Inc (CNCE) · $662 million at peak · was bought or merged
1975 · 1976 · 1977 · 1978 · 1979 · 1980 · 1981 · 1982 · 1983 · 1984 · 1985 · 1986 · 1987 · 1988 · 1989 · 1990 · 1991 · 1992 · 1993 · 1994 · 1995 · 1996 · 1997 · 1998 · 1999 · 2000 · 2001 · 2002 · 2003 · 2004 · 2005 · 2006 · 2007 · 2008 · 2009 · 2010 · 2011 · 2012 · 2013 · 2014 · 2015 · 2016 · 2017 · 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024